Today we speak with Dr. Nigel Strauss, a psychiatrist with over 40 years experience and Adjunct Professor at Deakin University.
Nigel’s career has focused on medico-legal psychiatry, in particular Post-Traumatic Stress Disorder (PTSD). He is Director of Occupational Psychiatry Pty. Ltd. which integrates psychiatry into the workplace.
Prompted by the extraordinary results of MDMA-assisted psychotherapy in the treatment of PTSD (which was recently granted breakthrough therapy designation by the US FDA), Nigel became interested in the therapeutic potential of MDMA and other psychedelics, a stigmatised but therapeutically promising class of drugs.
Nigel now advocates for psychedelic-research in Australia and has published a number of papers on the subject.
Millswyn Clinic – Nigel’s workplace
Multidisciplinary Association for Psychedelic Study
MDMA-assisted psychotherapy granted breakthrough therapy designation
Psylocibin-assisted psychotherapy granted breakthrough therapy designation
Nigel’s paper advocating for psychedelic research in Australia
Nigel’s paper on psilocybin-assisted therapy for terminally ill patients with anxiety and depression